Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2020-01-01–present
John B. Henneman III
Equibles does not estimate personal net worth.
About John B. Henneman III
John B. Henneman III is recorded as Board Member at Anika Therapeutics, Inc. (ANIK) since January 1, 2020. Anika Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Aprea Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Anika Therapeutics, Inc. includes Cheryl Blanchard (CEO and Board Member), Stephen (Steve) Griffin (CEO and Board Member), Stephen D. Griffin (CEO, CFO and Board Member) and 7 others.
Affiliation history
-
Aprea Therapeutics, Inc. (APRE)
SEC 8-K
Current2020-09-16–present
-
Current
2020-01-01–present
-
2019-01-01–2022-06-10
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Anika Therapeutics, Inc.
- Cheryl Blanchard CEO, Board Member
- Stephen (Steve) Griffin CEO, Board Member
- Stephen D. Griffin CEO, CFO, Board Member
- Steve Griffin CEO, Board Member
- Cheryl R. Blanchard Chairman, Board Member
- Jeffery S. Thompson Chairman
- John B. Henneman, III Chairman, Board Member
- Michael Levitz CFO
- Stephen Griffin CFO
- Anne Nunes COO
Leadership on record at Aprea Therapeutics, Inc.
- Oren Gilad CEO
- Richard Peters, M.D., Ph.D. Chairman, Board Member
- John Hamill CFO
- Scott M. Coiante CFO
- Greg Korbel COO
- Bernd Seizinger Board Member
- Fouad Namouni, M.D. Board Member
- Gabriela Gruia Board Member
- Gabriela Gruia, M.D. Board Member
- Jean-Pierre Bizzari Board Member
Recent activity
No call appearances or filed executive changes recorded yet.